| Inflammation and aortic pulse wave velocity: a multicenter longitudinal study in patients with inflammatory bowel disease L Zanoli, K Ozturk, M Cappello, G Inserra, G Geraci, A Tuttolomondo, ... Journal of the American Heart Association 8 (3), e010942, 2019 | 49 | 2019 |
| Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy C Karacin, T Eren, E Zeynelgil, GI Imamoglu, M Altinbas, I Karadag, ... Future Oncology 17 (33), 4447-4456, 2021 | 38 | 2021 |
| Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: a multicenter study HÇ Yıldırım, E Mutlu, E Chalabiyev, M Özen, M Keskinkılıç, S Ön, A Çelebi, ... The Breast 66, 85-88, 2022 | 6 | 2022 |
| Secondary pneumothorax during immunotherapy in two patients with metastatic solid tumors; a new entity A Kucukarda, S Sayın, A Gokyer, MB Aykan, N Karadurmuş, İ Cicin Immunotherapy 13 (7), 565-570, 2021 | 6 | 2021 |
| Seizure Induced by Ertazepam in an Elderly Patient with Dementia A Aydın, MB Aykan, K Sağlam | 6 | 2017 |
| Evaluation of the effects of different treatment modalities on angiogenesis in heart failure patients with reduced/mid-range ejection fraction via VEGF and sVEGFR-1 I Erturk, K Saglam, S Elasan, MB Aykan, R Acar, F Yesildal, FN Aydin, ... Saudi Medical Journal 39 (10), 1028, 2018 | 5 | 2018 |
| Comparison of anthropometric measurements for prediction of the atherosclerosis and liver histology in young adults with nonalcoholic fatty liver disease T Dogan, K Ozturk, S Celikkanat, MB Aykan, A Uygun European Journal of Gastroenterology & Hepatology 31 (11), 1460-1466, 2019 | 4 | 2019 |
| Morvan syndrome: a rare cause of syndrome of inappropriate antidiuretic hormone secretion S Demirbas, MB Aykan, H Zengin, S Mazman, K Saglam Clujul Medical 90 (3), 353, 2017 | 4 | 2017 |
| First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer SA Esen, Y Ergun, C Erol, R Arikan, MM Er, MM Atci, A Topçu, G Uçar, ... Bosnian journal of basic medical sciences 22 (5), 818, 2022 | 3 | 2022 |
| High-dose Chemotherapy Response in Adults with Relapsed/Refractory Small Round Cell Tumours MB Aykan, I Erturk, R Acar, GS Yildiran, B Yildiz, N Karadurmus Journal of the College of Physicians and Surgeons Pakistan 26 (8.57), 29.40-8.98, 2022 | 3 | 2022 |
| Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer S Kahraman, E Erul, M Seyyar, O Gumusay, E Bayram, BC Demirel, ... Future Oncology 19 (10), 727-736, 2023 | 2 | 2023 |
| Real-life analysis of treatment approaches and the role of inflammatory markers on survival in patients with advanced biliary tract cancer S Goktas Aydin, B Cakan Demirel, A Bilici, A Topcu, MB Aykan, ... Current medical research and opinion 38 (10), 1751-1758, 2022 | 2 | 2022 |
| Treating relapsed and refractory metastatic germ cell tumours with high-dose chemotherapy with carboplatin and etoposide and autologous haematopoietic stem cell transplantation I Erturk, N Karadurmus, H Kızıloz, R Acar, B Yildiz, MB Aykan, R Esen, ... Journal of Oncology Pharmacy Practice 27 (7), 1657-1664, 2021 | 2 | 2021 |
| Clinical presentation and course of the novel coronavirus disease 2019 in patients with various types of cancer: A retrospective case–control analysis of an experienced cancer … R Acar, G Yilmaz, U Savasci, MB Aykan, H Kiziloz, F Cuce, E Kadioglu, ... Journal of Cancer Research and Therapeutics 17 (2), 556-564, 2021 | 2 | 2021 |
| Gemcitabine, oxaliplatin and paclitaxel (Gempox) in patients with relapsed or refractory germ cell tumors after high dose chemotherapy, a retrospective single-center experience R Acar, I Erturk, H Kiziloz, S Okcelik, B Yildiz, M Aykan, G Keskin, ... UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI 30 (4), 2020 | 2 | 2020 |
| Interpretation of blood apelin level across different clinical pictures of diabetes mellitus MB Aykan, I Tasci Diabetes research and clinical practice 152, 183-184, 2019 | 2 | 2019 |
| The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer … HÇ Yıldırım, Y Kutlu, E Mutlu, MB Aykan, M Korkmaz, S Yalçın, T Şakalar, ... International Journal of Clinical Oncology, 1-8, 2024 | 1 | 2024 |
| Abstract P4-03-40: Patient and treatment characteristics in HR+/HER2-metastatic breast cancer in a real-life setting N Karadurmus, MAN Sendur, T Cil, OBC Oksuzoglu, C Arslan, ... Cancer Research 83 (5_Supplement), P4-03-40-P4-03-40, 2023 | 1 | 2023 |
| Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study SG Aydin, EE Kavak, A Topcu, A Bayramgil, F Akgul, S Kahraman, ... Biomolecules and biomedicine, 2023 | 1 | 2023 |
| The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2 … Ö Özdemir, B Zengel, Y Yildiz, BO Uluç, D Cabuk, E Ozden, DK Salim, ... Anti-Cancer Drugs 33 (7), 663-670, 2022 | 1 | 2022 |
